1) ACTOS
盐酸皮格列酮
2) ACTOS
匹格列酮盐酸盐
3) Pioglitazone Hydrochloride
盐酸吡格列酮
1.
Research to manufacture the Pioglitazone Hydrochloride orally disintegrating tablets;
盐酸吡格列酮口腔崩解片的研制
2.
Determination of Pioglitazone Hydrochloride Tablets by HPLC;
盐酸吡格列酮片的HPLC含量测定方法
4) pioglitazone hydrochloride tablets
盐酸吡格列酮片
1.
Dissolution comparison of pioglitazone hydrochloride tablets from different producers by process analysis;
过程分析比较不同厂家盐酸吡格列酮片的溶出度
2.
Pharmacokinetics of pioglitazone hydrochloride tablets in healthy human subjects after a single dose administration;
单剂口服盐酸吡格列酮片在健康人体的药代动力学
3.
Studies on the dissoulution rate of pioglitazone hydrochloride tablets;
盐酸吡格列酮片的溶出度研究
5) Pioglitazone
盐酸吡格列酮
1.
Effects of pioglitazone on the insulin resistance in the muscle tissue;
盐酸吡格列酮对肌肉组织胰岛素抵抗发生的影响
2.
Study on the prevention of insulin resistance of pioglitazone in the rats induced by high-fat diet;
盐酸吡格列酮对高脂诱导大鼠胰岛素抵抗的干预作用
3.
The clinical research of Pioglitazone treating typeⅡdiabeties;
盐酸吡格列酮治疗2型糖尿病临床研究
6) rosiglitazone
盐酸罗格列酮
1.
Effect of rosiglitazone on the proliferation and NO secretion of cultured cardiac fibroblasts induced by AGEs;
盐酸罗格列酮对糖基化终产物诱导心肌成纤维细胞增殖及分泌NO的影响
2.
Objective To establish a method for the determination of rosiglitazone in sustained-release tablets.
0)-甲醇(体积比25∶75)为流动相,检测波长247 nm,测定盐酸罗格列酮缓释片的含量。
补充资料：盐酸皮格列酮
分子式：C19H20N2O3S·HCl
分子量：392.90
CAS号：112529-15-4
性质：外观 白色晶体粉末熔程 193-194℃
制备方法：暂无
用途：新一代二型糖尿病治疗药，副作用小。
分子量：392.90
CAS号：112529-15-4
性质：外观 白色晶体粉末熔程 193-194℃
制备方法：暂无
用途：新一代二型糖尿病治疗药，副作用小。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条